期刊
BRAIN SCIENCES
卷 12, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/brainsci12070933
关键词
obsessive-compulsive disorder; deep brain stimulation; anterior limb of internal capsule; nucleus accumbens
资金
- Shanghai Science and Technology Committee [20XD1423100]
- Shanghai Clinical Research Center for Mental Health [19MC1911100]
This study aims to evaluate the efficacy and safety of combined ALIC- and NAcc-DBS for treatment-refractory OCD. A total of 64 patients will be recruited and randomly allocated to active and sham-stimulation groups. Primary outcome measures include treatment response rate and adverse events, while secondary outcome measures include changes in multiple scale scores.
Backgrounds: Deep brain stimulation (DBS) is an emerging and promising therapeutic approach for treatment-refractory obsessive-compulsive disorder (OCD). The most common DBS targets include the anterior limb of internal capsule (ALIC) and nucleus accumbens (NAcc). This protocol aims to explore the efficacy and safety of the combined ALIC- and NAcc-DBS for treatment-refractory OCD. Methods: We will recruit 64 patients with refractory OCD from six centers, randomly allocate them to active and sham-stimulation groups through a three-month double-blind phase, then enter a three-month open-label phase. In the open-label stage, both groups experience real stimulation. Outcome measures: The primary outcome will be the efficacy and safety of combined ALIC- and NAcc-DBS, determined by treatment response rate between the active and sham-stimulation groups at the double-blind stage and spontaneously reported adverse events. The secondary outcomes are comparisons of change in Y-BOCS, CGI, HAMD, and HAMA scores at the third and sixth months compared to baseline between the active and sham-control groups, as well as the scores of the third month minus the sixth month between the two groups.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据